VOIR ÉGALEMENT...
TAF Basal Transcription Factor Anticorps
| Empty Table Header | Nom du produit | CATALOG # | Isotype | Épitope | Applications | Species | CITATIONS | Classement |
|---|---|---|---|---|---|---|---|---|
Anticorps TAF I p48 (A-10) | sc-393600 | mouse IgG1 κ | 225-300 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
Anticorps TAF I p110 (C-10) | sc-374551 | mouse IgG1 κ | 570-869 (h) | WB, IP, IF, ELISA | h | 2 | ||
Anticorps TAF I p110/p95 (D-8) | sc-376802 | mouse IgG1 κ | 570-869 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF II p18 (A-5) | sc-393319 | mouse IgG2b κ | FL (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF II p20 (B-6) | sc-514619 | mouse IgG1 κ | FL (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF II p28 (A-4) | sc-393100 | mouse IgG2b κ | 54-211 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF II p28 (G-1) | sc-393101 | mouse IgG1 κ | 54-211 (h) | WB, IP, IF, ELISA | h | new | ||
Anticorps TAF II p43 (B-7) | sc-398062 | mouse IgG2a κ | 40-310 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
Anticorps TAF II p55 (SQ-8) | sc-101167 | mouse IgG2a κ | 130-224 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 3 | ||
Anticorps TAF II p68 (TAF15B11A6) | sc-81121 | mouse IgG1 | N-Terminal (h) | WB, IP | h | 2 | ||
Anticorps TAF II p70 (D-10) | sc-393842 | mouse IgG2a κ | 1-300 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF II p70 (585D4a) | sc-81124 | mouse IgG1 | C-Terminal (h) | WB, IP, IF | m, r, h | new | ||
Anticorps TAF II p100 (E-9) | sc-376932 | mouse IgG2a κ | 246-363 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF II p100 (H-3) | sc-374644 | mouse IgG3 κ | 263-293 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
Anticorps TAF II p105 (TAFAD26A) | sc-81122 | mouse IgG1 | C-Terminal (h) | WB, IP | h | new | ||
Anticorps TAF II p130 (4A6) | sc-736 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P) | h | 16 | ||
Anticorps TAF II p135 (22) | sc-136093 | mouse IgG1 κ | 454-565 (h) | WB, IP, IF | m, r, h | 10 | ||
Anticorps TAF II p170 (BTA3D61) | sc-81391 | mouse IgG1 | C-Terminal (h) | WB, IP, IF, FCM | m, r, h | new | ||
Anticorps TAF II p250 (6B3) | sc-735 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 68 | ||
Anticorps TAF II p250 (A-10) | sc-393981 | mouse IgG2b κ | 1276-1315 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF1L (N3T) | sc-130485 | mouse IgG2a κ | 1532-1642 (h) | IF, IHC(P), ELISA | h | new | ||
Anticorps TAF9A/B (G-1) | sc-271463 | mouse IgG1 κ | 37-131 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
Anticorps TAF9B (3365C4a) | sc-81125 | mouse IgG2b | Internal (h) | WB, IP | h | new |
TAF Basal Transcription Factor CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nom du produit | CATALOG # | Species | Applications | MARQUEUR | CITATIONS | Classement |
|---|---|---|---|---|---|---|---|
Plasmide Double Nickase (h) TAF5L | sc-408861-NIC | h | Gene Knockout | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO TAF II p100 (h) | sc-407475 | h | Gene Knockout | GFP | 0 | ||
Plasmid HDR TAF II p100 (h) | sc-407475-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO TAF II p135 (h) | sc-404230 | h | Gene Knockout | GFP | 0 | ||
Plasmid HDR TAF II p150 (h) | sc-407643-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO TAF II p250 (h) | sc-402218 | h | Gene Knockout | GFP | 0 | ||
Plasmid HDR TAF II p250 (h) | sc-402218-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO TAF II p250 (m) | sc-435426 | m | Gene Knockout | GFP | 0 |
TAF Basal Transcription Factor CRISPR Activation Products
| Empty Table Header | Nom du produit | CATALOG # | Species | Applications | MARQUEUR | CITATIONS | Classement |
|---|---|---|---|---|---|---|---|
Plasmide CRISPR d'Activation (h) TAF I p63 | sc-404427-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h) TAF II p135 | sc-404230-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h) TAF II p250 | sc-402218-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h2) TAF II p250 | sc-402218-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
TAF Basal Transcription Factor siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Nom du produit | CATALOG # | Species | Applications | MARQUEUR | CITATIONS | Classement |
|---|---|---|---|---|---|---|---|
TAF1L siRNA (h) | sc-106597 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF1L (h) | sc-106597-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF1L (h) | sc-106597-V | h | Gene Silencing | Puromycin | 0 | ||
TAF5L siRNA (h) | sc-88360 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF5L (h) | sc-88360-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF5L (h) | sc-88360-V | h | Gene Silencing | Puromycin | 0 | ||
TAF5L siRNA (m) | sc-106598 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF5L (m) | sc-106598-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF5L (m) | sc-106598-V | m | Gene Silencing | Puromycin | 0 | ||
TAF6L siRNA (h) | sc-96582 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF6L (h) | sc-96582-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF6L (h) | sc-96582-V | h | Gene Silencing | Puromycin | 0 | ||
TAF6L siRNA (m) | sc-154053 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF6L (m) | sc-154053-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF6L (m) | sc-154053-V | m | Gene Silencing | Puromycin | 0 | ||
TAF7L siRNA (h) | sc-90911 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF7L (h) | sc-90911-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF7L (h) | sc-90911-V | h | Gene Silencing | Puromycin | 0 | ||
TAF7L siRNA (m) | sc-154054 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF7L (m) | sc-154054-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF7L (m) | sc-154054-V | m | Gene Silencing | Puromycin | 0 | ||
TAF9B siRNA (m) | sc-154055 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF9B (m) | sc-154055-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF9B (m) | sc-154055-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p18 siRNA (h) | sc-38492 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p18 (h) | sc-38492-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p18 (h) | sc-38492-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p18 siRNA (m) | sc-38493 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p18 (m) | sc-38493-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p18 (m) | sc-38493-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p20 siRNA (h) | sc-88359 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p20 (h) | sc-88359-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p20 (h) | sc-88359-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p20 siRNA (m) | sc-106595 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p20 (m) | sc-106595-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p20 (m) | sc-106595-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p28 siRNA (h) | sc-38494 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p28 (h) | sc-38494-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p28 (h) | sc-38494-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p28 siRNA (m) | sc-38495 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p28 (m) | sc-38495-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p28 (m) | sc-38495-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p30 siRNA (h) | sc-96590 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p30 (h) | sc-96590-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p30 (h) | sc-96590-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p32 siRNA (h) | sc-38496 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p32 (h) | sc-38496-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p32 (h) | sc-38496-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p32 siRNA (m) | sc-38497 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p32 (m) | sc-38497-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p32 (m) | sc-38497-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p43 siRNA (h) | sc-95445 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p43 (h) | sc-95445-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p43 (h) | sc-95445-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p43 siRNA (m) | sc-154051 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p43 (m) | sc-154051-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p43 (m) | sc-154051-V | m | Gene Silencing | Puromycin | 0 | ||
TAF I p48 siRNA (h) | sc-38486 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF I p48 (h) | sc-38486-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF I p48 (h) | sc-38486-V | h | Gene Silencing | Puromycin | 0 | ||
TAF I p48 siRNA (m) | sc-38487 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF I p48 (m) | sc-38487-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF I p48 (m) | sc-38487-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p55 siRNA (h) | sc-76627 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p55 (h) | sc-76627-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p55 (h) | sc-76627-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p55 siRNA (m) | sc-76628 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p55 (m) | sc-76628-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p55 (m) | sc-76628-V | m | Gene Silencing | Puromycin | 0 | ||
TAF I p63 siRNA (h) | sc-38488 | h | Gene Silencing | 1 | |||
Plasmide shRNA TAF I p63 (h) | sc-38488-SH | h | Gene Silencing | 1 | |||
Particules Lentivirales shRNA TAF I p63 (h) | sc-38488-V | h | Gene Silencing | Puromycin | 1 | ||
TAF I p68 siRNA (m) | sc-38489 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF I p68 (m) | sc-38489-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF I p68 (m) | sc-38489-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p68 siRNA (h) | sc-94009 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p68 (h) | sc-94009-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p68 (h) | sc-94009-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p68 siRNA (m) | sc-154052 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p68 (m) | sc-154052-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p68 (m) | sc-154052-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p70 siRNA (h) | sc-89790 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p70 (h) | sc-89790-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p70 (h) | sc-89790-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p70 siRNA (m) | sc-106596 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p70 (m) | sc-106596-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p70 (m) | sc-106596-V | m | Gene Silencing | Puromycin | 0 | ||
TAF I p95 siRNA (m) | sc-38491 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF I p95 (m) | sc-38491-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF I p95 (m) | sc-38491-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p100 siRNA (h) | sc-38498 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p100 (h) | sc-38498-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p100 (h) | sc-38498-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p100 siRNA (m) | sc-154044 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p100 (m) | sc-154044-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p100 (m) | sc-154044-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p105 siRNA (h) | sc-76625 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p105 (h) | sc-76625-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p105 (h) | sc-76625-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p105 siRNA (m) | sc-154045 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p105 (m) | sc-154045-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p105 (m) | sc-154045-V | m | Gene Silencing | Puromycin | 0 | ||
TAF I p110 siRNA (h) | sc-38490 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF I p110 (h) | sc-38490-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF I p110 (h) | sc-38490-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p135 siRNA (h) | sc-76626 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p135 (h) | sc-76626-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p135 (h) | sc-76626-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p135 siRNA (m) | sc-154046 | m | Gene Silencing | N/A | 0 | ||
TAF II p140 siRNA (h) | sc-90793 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p140 (h) | sc-90793-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p140 (h) | sc-90793-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p140 siRNA (m) | sc-154047 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p140 (m) | sc-154047-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p140 (m) | sc-154047-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p150 siRNA (h) | sc-77487 | h | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p150 (h) | sc-77487-SH | h | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p150 (h) | sc-77487-V | h | Gene Silencing | Puromycin | 0 | ||
TAF II p150 siRNA (m) | sc-154048 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p150 (m) | sc-154048-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p150 (m) | sc-154048-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p170 siRNA (h) | sc-38500 | h | Gene Silencing | N/A | 1 | ||
Plasmide shRNA TAF II p170 (h) | sc-38500-SH | h | Gene Silencing | Puromycin | 1 | ||
Particules Lentivirales shRNA TAF II p170 (h) | sc-38500-V | h | Gene Silencing | Puromycin | 1 | ||
TAF II p170 siRNA (m) | sc-154049 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p170 (m) | sc-154049-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p170 (m) | sc-154049-V | m | Gene Silencing | Puromycin | 0 | ||
TAF II p250 siRNA (h) | sc-37169 | h | Gene Silencing | N/A | 1 | ||
Plasmide shRNA TAF II p250 (h) | sc-37169-SH | h | Gene Silencing | Puromycin | 1 | ||
Particules Lentivirales shRNA TAF II p250 (h) | sc-37169-V | h | Gene Silencing | Puromycin | 1 | ||
TAF II p250 siRNA (m) | sc-37170 | m | Gene Silencing | N/A | 0 | ||
Plasmide shRNA TAF II p250 (m) | sc-37170-SH | m | Gene Silencing | Puromycin | 0 | ||
Particules Lentivirales shRNA TAF II p250 (m) | sc-37170-V | m | Gene Silencing | Puromycin | 0 |